Surgery Partners, Inc. (SGRY) › Cash & EquivalentsSurgery Partners, Inc. (SGRY) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $5.23M2013: $13.03M2014: $74.92M2015: $57.93M2016: $69.70M2017: $174.91M2018: $184.30M2019: $92.70M2020: $317.90M2021: $389.90M2022: $282.90M2023: $195.90M2024: $269.50M2025: $239.90M$239.90M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$239.90M-11.0%2024$269.50M+37.6%2023$195.90M-30.8%2022$282.90M-27.4%2021$389.90M+22.6%2020$317.90M+242.9%2019$92.70M-49.7%2018$184.30M+5.4%2017$174.91M+151.0%2016$69.70M+20.3%2015$57.93M-22.7%2014$74.92M+475.2%2013$13.03M+149.0%2012$5.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share